These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 26799114)

  • 41. Combination therapy of long-acting beta2-adrenoceptor agonists and corticosteroids for asthma.
    Chung KF; Adcock IM
    Treat Respir Med; 2004; 3(5):279-89. PubMed ID: 15606218
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Increased Dose of Inhaled Corticosteroid versus Add-On Long-acting β-Agonist for Step-Up Therapy in Asthma.
    Israel E; Roche N; Martin RJ; Colice G; Dorinsky PM; Postma DS; Guilbert TW; van Aalderen WM; Grigg J; Hillyer EV; Burden A; von Ziegenweidt J; Thomas V; Price DB
    Ann Am Thorac Soc; 2015 Jun; 12(6):798-806. PubMed ID: 25756308
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Omalizumab: an update on efficacy and safety in moderate-to-severe allergic asthma.
    Chipps BE; Figliomeni M; Spector S
    Allergy Asthma Proc; 2012; 33(5):377-85. PubMed ID: 23026179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pragmatic Randomized Controlled Trial for Stepping Down Asthma Controller Treatment in Patients Controlled with Low-Dose Inhaled Corticosteroid and Long-Acting β
    Kim SH; Lee T; Jang AS; Park CS; Jung JW; Kim MH; Kwon JW; Moon JY; Yang MS; Lee J; Choi JH; Shin YS; Kim HK; Kim S; Kim JH; Lee SY; Nam YH; Kim SH; Kim TB;
    J Allergy Clin Immunol Pract; 2021 Oct; 9(10):3638-3646.e3. PubMed ID: 33940213
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Do inhaled corticosteroid/long-acting beta2-agonist fixed combinations provide superior clinical benefits compared with separate inhalers? A literature reappraisal.
    Barnes PJ; Nicolini G; Bizzi A; Spinola M; Singh D
    Allergy Asthma Proc; 2012; 33(2):140-4. PubMed ID: 22525390
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The use of inhaled formoterol in the treatment of asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Benefit-risk assessment of long-acting beta2-agonists in asthma.
    Jackson CM; Lipworth B
    Drug Saf; 2004; 27(4):243-70. PubMed ID: 15003036
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nocturnal asthma uncontrolled by inhaled corticosteroids: theophylline or long-acting beta2 agonists?
    Holimon TD; Chafin CC; Self TH
    Drugs; 2001; 61(3):391-418. PubMed ID: 11293649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Long-acting beta2-adrenergic agonist in pediatric and adolescent asthma patients, 2003-2011.
    Zhou EH; Kang EM; Seymour S; Iyasu S
    J Asthma; 2014 Dec; 51(10):1061-7. PubMed ID: 24945885
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effect of stepping down combination therapy on airway hyperresponsiveness to mannitol.
    Kersten ET; Driessen JM; Duiverman EJ; Thio BJ
    Respir Med; 2011 May; 105(5):691-7. PubMed ID: 21129943
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Combination inhalers containing inhaled corticosteroids and long-acting beta2-agonists: improved clinical efficacy and dosing options in patients with asthma.
    Ankerst J
    J Asthma; 2005 Nov; 42(9):715-24. PubMed ID: 16316864
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Second-line controller therapy for persistent asthma uncontrolled on inhaled corticosteroids: the step 3 dilemma.
    Lipworth BJ; Jackson CM
    Drugs; 2002; 62(16):2315-32. PubMed ID: 12396225
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A re-evaluation of the role of inhaled corticosteroids in the management of patients with chronic obstructive pulmonary disease.
    D'Urzo A; Donohue JF; Kardos P; Miravitlles M; Price D
    Expert Opin Pharmacother; 2015; 16(12):1845-60. PubMed ID: 26194213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Balancing safety and efficacy in pediatric asthma management.
    Skoner DP
    Pediatrics; 2002 Feb; 109(2 Suppl):381-92. PubMed ID: 11826254
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative efficacy of inhalers in mild-to-moderate asthma: systematic review and network meta-analysis.
    Park HJ; Huh JY; Lee JS; Lee JS; Oh YM; Lee SW
    Sci Rep; 2022 Apr; 12(1):5949. PubMed ID: 35396495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Tiotropium for the treatment of asthma in adolescents.
    Hamelmann E; Vogelberg C; Szefler SJ
    Expert Opin Pharmacother; 2017 Feb; 18(3):305-312. PubMed ID: 28110558
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Asthma control factors in the Gulf Cooperation Council (GCC) countries and the effectiveness of ICS/LABA fixed dose combinations: a dual rapid literature review.
    Noibi S; Mohy A; Gouhar R; Shaker F; Lukic T; Al-Jahdali H
    BMC Public Health; 2020 Aug; 20(1):1211. PubMed ID: 32770967
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment options for initial maintenance therapy of persistent asthma: a review of inhaled corticosteroids and leukotriene receptor antagonists.
    Creticos PS
    Drugs; 2003; 63 Suppl 2():1-20. PubMed ID: 14984077
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Inhaled corticosteroids plus long-acting beta2-agonists as a combined therapy in asthma.
    García-Marcos L; Schuster A; Cobos Barroso N
    Expert Opin Pharmacother; 2003 Jan; 4(1):23-39. PubMed ID: 12517241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.